COSENZA, Maria

COSENZA, Maria  

Dipartimento di Scienze Mediche e Chirurgiche Materno-Infantili e dell'Adulto  

Mostra records
Risultati 1 - 19 di 19 (tempo di esecuzione: 0.098 secondi).
Titolo Data di pubblicazione Autore(i) File
Activity of BKM120 and BEZ235 against lymphoma cells 1-gen-2015 Civallero, Monica; Cosenza, Maria; Pozzi, Samantha; Bari, Alessia; Ferri, Paola; Sacchi, Stefano
Biological effects of Atra and Arsenic Trioxide on short term cultures of non-M3 leukemic blasts 1-gen-2005 Cosenza, Maria; Civallero, Monica; Sacchi, Stefano; Marcheselli, Raffaella; Pozzi, Samantha
Calcium-Carbonate Nanocapsules Improve the Efficacy of BEZ235 in Lymphoma a Cell Line: A Promising New Technology of Drug Delivery 1-gen-2015 Civallero, Monica; Vergaro, Viviana; Citti, Cinzia; Cosenza, Maria; Cannazza, Giuseppe; Parenti, Carlo; Bari, Alessia; Ciccarella, Giuseppe; Sacchi, Stefano; Pozzi, Samantha
Cell-penetrating CaCO3nanocrystals for improved transport of NVP-BEZ235 across membrane barrier in T-cell lymphoma 1-gen-2018 Vergaro, Viviana; Civallero, Monica; Citti, Cinzia; Cosenza, Maria; Baldassarre, Francesca; Cannazza, Giuseppe; Pozzi, Samantha; Sacchi, Stefano; Fanizzi, Francesco Paolo; Ciccarella, Giuseppe
Citarinostat and Momelotinib co-target HDAC6 and JAK2/STAT3 in lymphoid malignant cell lines: a potential new therapeutic combination 1-gen-2020 Cosenza, M.; Civallero, M.; Marcheselli, L.; Sacchi, S.; Pozzi, S.
The combination of bortezomib with enzastaurin or lenalidomide enhances cytotoxicity in follicular and mantle cell lymphoma cell lines 1-gen-2015 Cosenza, Maria; Civallero, Monica; Pozzi, Samantha; Marcheselli, Luigi; Bari, Alessia; Sacchi, Stefano
Combination of low doses of Enzastaurin and Lenalidomide has synergistic activity in B-non-Hodgkin lymphoma cell lines 1-gen-2012 Cosenza, Maria; Civallero, Monica; Grisendi, Giulia; Marcheselli, Luigi; Roat, Erika; Bari, Alessia; Sacchi, Stefano
Effects of enzastaurin, alone or in combination, on signaling pathway controlling growth and survival of B-cell lymphoma cell lines. 1-gen-2010 Civallero, Monica; Cosenza, Maria; Grisendi, Giulia; Marcheselli, L; Todoerti, K; Sacchi, Stefano
Effects of Enzastaurin, Alone or in Combination, on Signalling Pathway Controlling Growth and Survival of B-Cell Lymphoma Cell LinesBlood (ASH Annual Meeting Abstracts), Nov 2008; 112: 4978 1-gen-2008 Sacchi, Stefano; Civallero, Monica; Cosenza, Maria; Grisendi, Giulia; Luigi, Marcheselli; Antonino, Neri
Genomic profiling of enzastaurin-treated B cell lymphoma RL cells 1-gen-2011 Civallero, Monica; Cosenza, Maria; Neri, Antonino; Bari, Alessia
The histone deacetylase inhibitor romidepsin synergizes with lenalidomide and enhances tumor cell death in T-cell lymphoma cell lines 1-gen-2016 Cosenza, Maria; Civallero, Monica; Fiorcari, Stefania; Pozzi, Samantha; Marcheselli, Luigi; Bari, Alessia; Ferri, Paola; Sacchi, Stefano
Molecular targeting of the PKC-beta inhibitor enzastaurin (LY317615) in multiple myeloma involves a coordinated downregulation of MYC and IRF4 expression. 1-gen-2009 Verdelli, D; Nobili, L; Todoerti, K; Intini, D; Cosenza, Maria; Civallero, Monica; Bertacchini, Jessika; Deliliers, Gl; Sacchi, Stefano; Lombardi, L; Neri, A.
NVP-BEZ235 alone and in combination in mantle cell lymphoma: an effective therapeutic strategy 1-gen-2012 Civallero, Monica; Cosenza, Maria; Marcheselli, Luigi; Pozzi, Samantha; Sacchi, Stefano
Rational combinations of enzastaurin with novel targeted agents for patients with B-cell non-Hodgkin's lymphoma 1-gen-2011 Civallero, Monica; Cosenza, Maria; Bari, Alessia; Sacchi, Stefano
Ricolinostat, a selective HDAC6 inhibitor, shows anti-lymphoma cell activity alone and in combination with bendamustine 1-gen-2017 Cosenza, Maria; Civallero, Monica; Marcheselli, Luigi; Sacchi, Stefano; Pozzi, Samantha
Ruxolitinib combined with vorinostat suppresses tumor growth and alters metabolic phenotype in hematological diseases 1-gen-2017 Civallero, Monica; Cosenza, Maria; Pozzi, Samantha; Sacchi, Stefano
Systemic sarcoidosis associated with interferon-alpha treatment for chronic myelogenous leukemia 1-gen-2000 C., Fiorani; Sacchi, Stefano; G., Bonacorsi; Cosenza, Maria
The Oral PKC-ß Inhibitor Enzastaurin (LY317615) Suppress Phosphorylation and Induces Apoptosis in Multiple Myeloma Cell Lines by Inhibition of AKT Pathway. 1-gen-2006 Antonino, Neri; Marmiroli, Sandra; Pierfrancesco, Tassone; Luigia, Lombardi; Lucia, Nobili; Donata, Verdelli; Civallero, Monica; Cosenza, Maria; Jessika, Bertacchini; Federico, Massimo; DE POL, Anto; Giorgio Lambertenghi, Deliliers; Sacchi, Stefano
The therapeutic strategy of HDAC6 inhibitors in lymphoproliferative disease 1-gen-2018 Cosenza, M.; Pozzi, S.